Navigation Links
Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors
Date:10/12/2011

CRANBURY, N.J., Oct. 12, 2011 /PRNewswire/ -- Oncobiologics, Inc. announced today that is has named Scott Canute, a former President at both Eli Lilly and Genzyme, to its Board of Directors.  

Over the course of his 30-year career, Mr. Canute played a vital role in leading Eli Lilly's global manufacturing operations.  Most recently, he spent more than a year as President of Global Manufacturing and Corporate Operations for Genzyme, where he led a major turnaround effort.

"Scott Canute has been a distinguished leader at major biopharmaceutical organizations throughout his career," said Oncobiologics Founder & CEO Pankaj Mohan, Ph.D.  "I have known and admired Scott as my mentor for many years, and I am honored that he will share his experience and strategic insight to our efforts at Oncobiologics.  We look forward to guidance from Scott as a member of our board."

"Oncobiologics has assembled an impressive team of industry leaders, and already has developed a promising pipeline," said Mr. Canute.  "Although the company is a start-up, it has the horsepower of a much more established organization.  I look forward to helping Pankaj steer the company through this exciting stage."

Mr. Canute earned a Master of Business Administration from the Harvard Business School.  He also earned a B.S. in Chemical Engineering at the University of Michigan, where he graduated with Highest Honors.

About Oncobiologics, Inc.

Headquartered in Cranbury, N.J., Oncobiologics is utilizing a proprietary platform to develop a pipeline of next generation biotherapeutics focused on clinically validated targets in the therapeutic areas of oncology, immuno-oncology, and immunology. Oncobiologics provides world-class, turnkey proof-of-concept services that can take a partner's pre-clinical candidates from chemistry, manufacture and control development through Phase II clinical trials. For more information, please visit www.oncobiologics.com or call 609-619-3990.


'/>"/>
SOURCE Oncobiologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Omeros Appoints David A. Mann to its Board of Directors
4. RainDance Technologies Appoints Olex Vice President, System Development
5. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
6. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
7. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
8. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
9. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
10. UltraShape Appoints Assaf Eyal as President & CEO
11. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global Healthcare Innovation Competition ... Week Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center that ... careful process of evaluation, twelve companies out of over 200 applications were selected ...
(Date:9/11/2019)... ... September 09, 2019 , ... ... for clinical trial randomization and drug supply chain management, today announced its new ... global life sciences industry. , “The integration between Veeva Vault EDC and our ...
(Date:9/11/2019)... SOMERSET, N.J. (PRWEB) , ... September 10, 2019 ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health ... Pharma Forum, to be held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, ...
(Date:9/8/2019)... ... 04, 2019 , ... The Blavatnik Family Foundation ... Winners and six Finalists of the 2019 Blavatnik Regional Awards for Young ... New Jersey, and Connecticut since 2007, the Blavatnik Regional Awards recognize outstanding researchers ...
Breaking Biology Technology:
(Date:9/22/2019)... ... 2019 , ... A new report from Strategic Directions International ... products. The report, Lab Instrumentation Markets for Pharmaceuticals, Biopharmaceuticals, & CROs , ... the largest source of demand for laboratory instrumentation. , With the rise ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock ... engineers from the Medical University of Warsaw, met at the Presidential Palace of ... creating a neuroprosthetic system as part of an initiative called "Startups in the ...
(Date:9/14/2019)... ... September 12, 2019 , ... Catalent, the leading global provider ... and consumer health products, today announced that professor David Schaffer has been appointed ... an integral advisory role on the gene therapy industry, as Catalent has moved ...
Breaking Biology News(10 mins):